CRANBURY, N.J., Nov. 27, 2024 (GLOBE NEWSWIRE) -- It’s an appointment with excellence! The PharmaceuticalExecutive APEX Awards, the only advertising awards program judged exclusively by doctors, ...
Giant cell tumor of bone (GCTB) is a rare primary osteolytic bone tumor with high local recurrence rate after surgical resection. Here the authors conduct a phase Ib/II trial, evaluating the ...
The company's stock slumped 7% on Tuesday after analysts at Cantor Fitzgerald said their review of early-stage data on Amgen's MariTide showed the drug had led to a drop in bone mineral density.